Severe anemia, sickle cell disease, and thalassemia as risk factors for hypertensive disorders in pregnancy in developing countries

Pregnancy Hypertension

Volumn 13, Issue , 2018, Pages 141-147

  Chen, Chang ^a   Grewal, Jagteshwar ^b   Betran, Ana Pilar ^c   Vogel, Joshua P ^c   Souza, Joāo Paulo ^c   Zhang, Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Anemia; Gestational hypertension; Preeclampsia; Sickle cell disease; Thalassemia

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTIPARA; NULLIPARA; PREECLAMPSIA; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; THALASSEMIA; URINARY TRACT INFECTION; YOUNG ADULT; AFRICA; ANEMIA; ASIA; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEALTH SURVEY; PATHOPHYSIOLOGY; PREGNANCY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SOUTH AND CENTRAL AMERICA;

ADULT; AFRICA; ANEMIA; ANEMIA, SICKLE CELL; ASIA; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LATIN AMERICA; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THALASSEMIA; YOUNG ADULT;

EID: 85048448710     PISSN: 22107789     EISSN: 22107797     Source Type: Journal    
DOI: 10.1016/j.preghy.2018.06.001     Document Type: Article

References (26)

1. Saleem, S., McClure, E.M., Goudar, S.S., Patel, A., Esamai, F., Garces, A., Chomba, E., Althabe, F., Moore, J., Kodkany, B., Pasha, O., Belizan, J., Mayansyan, A., Derman, R.J., Hibberd, P.L., Liechty, E.A., Krebs, N.F., Hambidge, K.M., Buekens, P., Carlo, W.A., Wright, L.L., Koso-Thomas, M., Jobe, A.H., Goldenberg, R.L., Global, I., Network Maternal Newborn Health Registry Study, A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries. Bull. World Health Organ 92:8 (2014), 605–612.
2. Mol, B.W., Roberts, C.T., Thangaratinam, S., Magee, L.A., de Groot, C.J., Hofmeyr, G.J., Pre-eclampsia. Lancet 387:10022 (2016), 999–1011.
3. Redman, C.W., Sargent, I.L., Latest advances in understanding preeclampsia. Science 308:5728 (2005), 1592–1594.
4. Iruela-Arispe, M.L., Normal placentation: a tale that requires an epithelial-to-endothelial conversion. J. Clin. Invest. 99:9 (1997), 2057–2058.
5. Hytten, F., Blood volume changes in normal pregnancy. Clin. Haematol. 14:3 (1985), 601–612.
6. Oteng-Ntim, E., Meeks, D., Seed, P.T., Webster, L., Howard, J., Doyle, P., Chappell, L.C., Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood 125:21 (2015), 3316–3325.
7. Ware, R.E., de Montalembert, M., Tshilolo, L., Abboud, M.R., Sickle cell disease. Lancet 390:10091 (2017), 311–323.
8. Taher, A.T., Weatherall, D.J., Cappellini, M.D., Thalassaemia. Lancet 391:10116 (2018), 155–167.
9. Villar, J., Valladares, E., Wojdyla, D., Zavaleta, N., Carroli, G., Velazco, A., Shah, A., Campodonico, L., Bataglia, V., Faundes, A., Langer, A., Narvaez, A., Donner, A., Romero, M., Reynoso, S., de Padua, K.S., Giordano, D., Kublickas, M., Acosta, A., W.H.O.g.s.o. maternal, g. perinatal health research, Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 367:9525 (2006), 1819–1829.
10. Shah, A., Faundes, A., Machoki, M., Bataglia, V., Amokrane, F., Donner, A., Mugerwa, K., Carroli, G., Fawole, B., Langer, A., Wolomby, J.J., Naravaez, A., Nafiou, I., Kublickas, M., Valladares, E., Velasco, A., Zavaleta, N., Neves, I., Villar, J., Methodological considerations in implementing the WHO Global Survey for Monitoring Maternal and Perinatal Health. Bull. World Health Organ 86:2 (2008), 126–131.
11. Goonewardene, M., Shehata, M., Hamad, A., Anaemia in pregnancy, Best practice & research. Clin. Obstet. Gynaecol. 26:1 (2012), 3–24.
12. Chakraborty, D., Cui, W., Rosario, G.X., Scott, R.L., Dhakal, P., Renaud, S.J., Tachibana, M., Rumi, M.A., Mason, C.W., Krieg, A.J., Soares, M.J., HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 113:46 (2016), E7212–E7221.
13. T.J. Kaitu'u-Lino, F.C. Brownfoot, R. Hastie, A. Chand, P. Cannon, M. Deo, L. Tuohey, C. Whitehead, N.J. Hannan, S. Tong, Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta, Hypertension (Dallas, Tex. : 1979) 70(5) (2017) 1014–1024.
14. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Libermann, T.A., Morgan, J.P., Sellke, F.W., Stillman, I.E., Epstein, F.H., Sukhatme, V.P., Karumanchi, S.A., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111:5 (2003), 649–658.
15. Smith, E.R., Shankar, A.H., Wu, L.S., Aboud, S., Adu-Afarwuah, S., Ali, H., Agustina, R., Arifeen, S., Ashorn, P., Bhutta, Z.A., Christian, P., Devakumar, D., Dewey, K.G., Friis, H., Gomo, E., Gupta, P., Kaestel, P., Kolsteren, P., Lanou, H., Maleta, K., Mamadoultaibou, A., Msamanga, G., Osrin, D., Persson, L.A., Ramakrishnan, U., Rivera, J.A., Rizvi, A., Sachdev, H.P.S., Urassa, W., West, K.P. Jr., Zagre, N., Zeng, L., Zhu, Z., Fawzi, W.W., Sudfeld, C.R., Modifiers of the effect of maternal multiple micronutrient supplementation on stillbirth, birth outcomes, and infant mortality: a meta-analysis of individual patient data from 17 randomised trials in low-income and middle-income countries. Lancet Glob Health 5:11 (2017), e1090–e1100.
16. Boafor, T.K., Olayemi, E., Galadanci, N., Hayfron-Benjamin, C., Dei-Adomakoh, Y., Segbefia, C., Kassim, A.A., Aliyu, M.H., Galadanci, H., Tuuli, M.G., Rodeghier, M., DeBaun, M.R., Oppong, S.A., Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. BJOG: Int. J. Obstet. Gynaecol. 123:5 (2016), 691–698.
17. Serjeant, G.R., Loy, L.L., Crowther, M., Hambleton, I.R., Thame, M., Outcome of pregnancy in homozygous sickle cell disease. Obstet. Gynecol. 103:6 (2004), 1278–1285.
18. Sun, P.M., Wilburn, W., Raynor, B.D., Jamieson, D., Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia,. Am. J. Obstet. Gynecol. 184:6 (2001), 1127–1130.
19. Villers, M.S., Jamison, M.G., De Castro, L.M., James, A.H., Morbidity associated with sickle cell disease in pregnancy. Am. J. Obstet. Gynecol., 199(2), 2008 125 e1-5.
20. Hassell, K., Pregnancy and sickle cell disease. Hematol. Oncol. Clin. North. Am. 19:5 (2005), 903–916.
21. Conde-Agudelo, A., Belizan, J.M., Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG Int. J. Obst. Gynaecol. 107:1 (2000), 75–83.
22. Tsaras, G., Owusu-Ansah, A., Boateng, F.O., Amoateng-Adjepong, Y., Complications associated with sickle cell trait: a brief narrative review. Am. J. Med. 122:6 (2009), 507–512.
23. Dhamcharee, V., Romyanan, O., Ninlagarn, T., Genetic counseling for thalassemia in Thailand: problems and solutions. Southeast Asian J. Trop. Med. Public Health 32:2 (2001), 413–418.
24. Tsatalas, C., Chalkia, P., Pantelidou, D., Margaritis, D., Bourikas, G., Spanoudakis, E., Pregnancy in beta-thalassemia trait carriers: an uneventful journey. Hematology 14:5 (2009), 301–303.
25. Poole, J.H., Thalassemia and pregnancy. J. Perinat. Neonatal Nurs. 17:3 (2003), 196–208.
26. Haram, K., Svendsen, E., Abildgaard, U., The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy and Childbirth, 9, 2009, 8.